Gender difference in improvement of endothelium-dependent vasodilation after estrogen supplementation

Journal of the American College of Cardiology

Volumn 30, Issue 4, 1997, Pages 914-919

  Kawano, Hiroaki ^a   Motoyama, Takeshi ^a   Kugiyama, Kiyotaka ^a   Hirashima, Osamu ^a   Ohgushi, Masamichi ^a   Fujii, Hiromi ^a   Ogawa, Hisao ^a   Yasue, Hirofumi ^a,b  

^a KUMAMOTO UNIV SCHOOL OF MEDICINE   (Japan)

^b KUMAMOTO UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ESTRADIOL; ESTROGEN; GLYCERYL TRINITRATE;

ADULT; AGED; ARTICLE; BLOOD VESSEL DIAMETER; BRACHIAL ARTERY; CLINICAL ARTICLE; ECHOGRAPHY; ESTROGEN ACTIVITY; ESTROGEN THERAPY; FEMALE; HUMAN; HYPEREMIA; MALE; POSTMENOPAUSE; PRIORITY JOURNAL; SEX DIFFERENCE; TRANSDERMAL DRUG ADMINISTRATION; VASCULAR ENDOTHELIUM; VASODILATATION;

ANALYSIS OF VARIANCE; BRACHIAL ARTERY; CARDIOVASCULAR DISEASES; ENDOTHELIUM, VASCULAR; ESTRADIOL; FEMALE; HUMANS; MALE; MIDDLE AGED; NITRIC OXIDE; NITROGLYCERIN; POSTMENOPAUSE; SEX CHARACTERISTICS; SINGLE-BLIND METHOD; VASODILATION; VASODILATOR AGENTS;

EID: 0030752658     PISSN: 07351097     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0735-1097(97)00234-9     Document Type: Article

References (46)

1. British Heart Foundation Statistics Database. Coronary Heart Disease Statistics, 1992. London: The Prevention Group, 1992.
2. Colditz GA, Willett WC, Stampfer MJ, Rosner B, Speizer FE, Hennekens CH. Menopause and the risk of coronary heart disease in women. N Engl J Med 1987;316:1105-10.
3. Witteman JCM, Grobbee DE, Kok FJ, Hofman A, Valkenburg HA. Increased risk of atherosclerosis in women after the menopause. Br Med J 1989;298:642-4.
4. Bush TL, Barrett-Connor E, Cowan LD, et al. Cardiovascular mortality and noncontraceptive use of estrogen in women: results from the Lipid Research Clinics Program Follow-up Study. Circulation 1987;75:1102-9.
5. Samaan SA, Crawford MH. Estrogen and cardiovascular function after menopause. J Am Coll Cardiol 1995;26:1403-10.
6. Stampfer MJ, Colditz GA, Willett WC, et al. Postmenopausal estrogen therapy and cardiovascular disease. N Engl J Med 1991;325:756-62.
7. Smith SC, Blair SN, Criqui MH, et al. Preventing heart attack and death in patients with coronary disease. Circulation 1995;92:2-4.
8. Kauser K, Rubanyi GM. Gender difference in bioassayable endothelium-derived nitric oxide from isolated rat aortae. Am J Physiol 1994;267: H2311-7.
9. Weiner CP, Lizasoain I, Baylis SA, Knowles RG, Charles IG, Moncada S. Induction of calcium-dependent nitric oxide synthases by sex hormones. Proc Natl Acad Sci U S A 1994;91:5212-6.
10. Hayashi T, Fukuto JM, Ignarro LJ, Chaudhuri G. Basal release of nitric oxide from aortic rings is greater in female rabbits than in male rabbits: implications for atherosclerosis. Proc Natl Acad Sci U S A 1992;89:11259-63.
11. Radomski MW, Palmer RMJ, Moncada S. Endogenous nitric oxide inhibits human platelet adhesion to vascular endothelium. Lancet 1987;2:1057-8.
12. Durante W, Kroll MH, Vanhoutte PM, Schafer AI. Endothelium-derived relaxing factor inhibits thrombin-induced platelet aggregation by inhibiting platelet phospholipase C. Blood 1992;79:110-6.
13. Dubey RK, Overbeck HW. Culture of rat mesenteric arteriolar smooth muscle cells: effects of platelet-derived growth factor, angiotensin, and nitric oxide on growth. Cell Tissue Res 1994;275:133-41.
14. Bath PMW, Hassall DG, Gladwin AM, Palmer RMJ, Martin JF. Nitric oxide and prostacyclin. Arterioscler Thromb 1991;11:254-60.
15. Moncada S, Palmer RMJ, Higgs EA. Nitric oxide: physiology, pathophysiology, and pharmacology. Pharmacol Rev 1991;43:109-42.
16. Celermajer DS, Sorensen KE, Gooch VM, et al. Non-invasive detection of endothelial dysfunction in children and adults at risk of atherosclerosis. Lancet 1992;340:1111-5.
17. Celermajer DS, Sorensen KE, Bull C, Robinson J, Deanfield JE. Endothelium-dependent dilation in the systemic arteries of asymptomatic subjects relates to coronary risk factors and their interaction. J Am Coll Cardiol 1994;24:1468-74.
18. Anderson TJ, Uehata A, Gerhard MD, et al. Close relation of endothelial function in human coronary and peripheral circulations. J Am Coll Cardiol 1995;26:1235-41.
19. Corretti MC, Plotnick GD, Vogel RA. Technical aspects of evaluating brachial artery endothelium-dependent vasodilatation using high frequency ultrasound. Am J Physiol 1995;268:H1397-404.
20. Kawano H, Motoyama T, Kugiyama K, et al. Menstrual cyclic variation of endothelium-dependent vasodilation of the brachial artery: possible role of estrogen and nitric oxide. Proc Assoc Am Physicians 1996;108:473-80.
21. Pignoli P, Tremoli E, Poli A, Oreste P, Paoletti R. Intimai plus medial thickness of the arterial wall: a direct measurement with ultrasound imaging. Circulation 1986;74:1399-406.
22. Gilligan DM, Badar DM, Panza JA, Quyyumi AA, Cannon RO. Acute vascular effects of estrogen in postmenopausal women. Circulation 1994;90: 786-91.
23. Noma A, Okabe H, Netsu-Nakayama K, Ueno Y, Shinohara H. Improved method for simultaneous determination of cholesterol in high- and low-density lipoproteins. Clin Chem 1979;25:1480-1.
24. 15N nitrate in biological fluids. Anal Biochem 1982;126:131-8.
25. Gilligan DM, Quyyumi AA, Cannon RO, Johnson GB, Schenke WH. Effects of physiological levels of estrogen on coronary vasomotor function in postmenopausal women. Circulation 1994;89:2545-51.
26. Vallance P, Collier J, Moncada S. Effect of endothelium-derived nitric oxide on peripheral arteriolar tone in man. Lancet 1989;28:997-1000.
27. Sinoway LI, Hendrickson C, Davidson WR, Prophet S, Zelis R. Characteristics of flow-mediated brachial artery vasodilation in human subjects. Circ Res 1989;64:32-42.
28. Nabel EG, Selwyn AP, Ganz P. Large coronary arteries in humans are responsive to changing blood flow: an endothelium-dependent mechanism that fails in patients with atherosclerosis. J Am Coll Cardiol 1990;16:349-56.
29. Drexler H, Zeiher AM, Wollschläger H, Meinertz T, Just H, Bonzel T. Flow-dependent coronary artery dilatation in humans. Circulation 1989;80: 466-74.
30. Rubanyi GM, Romero JC, Vanhoutte PM. Flow-induced release of endothelium-derived relaxing factor. Am J Physiol 1986;250:H1145-9.
31. Sessa WC, Pritchard K, Seyedi N, Wang J, Hintze TH. Chronic exercise in dogs increases coronary vascular nitric oxide production and endothelial cell nitric oxide synthase gene expression. Circ Res 1994;74:349-53.
32. Sugioka JM, Shimosegawa Y, Nakano MM. Estrogens as natural antioxidants of membrane lipid peroxidation. FEBS Lett 1987;210:37-9.
33. Keaney JF, Gaziano JM, Xu A, et al. 17-beta estradiol preserves endothelial vasodilator function and limits low-density lipoprotein oxidation in hypercholesterolemic swine. Circulation 1994;89:2251-9.
34. Collins P, Rosano GMC, Sarrel PM, et al. 17β-Estradiol attenuates acetylcholine-induced coronary arterial constriction in women but not men with coronary heart disease. Circulation 1995;92:24-30.
35. Rosser M, Chorich L, Howard E, Zamorano P, Mahesh VB. Changes in rat uterine estrogen receptor messenger ribonucleic acid levels during estrogen- and progesterone-induced estrogen receptor depletion and subsequent replenishment. Biol Reprod 1993;48:89-98.
36. Sparkes HV, Belloni FL. The peripheral circulation: local regulation. Annu Rev Physiol 1978;40:67-92.
37. Carlsson I, Sollevi I, Wennmalm A. The role of myogenic relaxation, adenosine and prostaglandines in human forearm reactive hyperemia. J Physiol (Paris) 1987;389:147-61.
38. Pohl U, Holtz J, Busse R, Bassenge E. Crucial role of endothelium in the vasodilator response to increased flow in vivo. Hypertension 1986;8:37-44.
39. Yamabe H, Okumura K, Ishizaka H, Tsuchiya T, Yasue H. Role of endothelium-derived nitric oxide in myocardial reactive hyperemia. Am J Physiol 1992;263:H8-14.
40. Tagawa T, Imaizumi T, Endo T, Shiramoto M, Harasawa Y, Takeshita A. Role of nitric oxide in reactive hyperemia in human forearm vessels. Circulation 1994;90:2285-90.
41. Vane JR, Anggard EE, Botting RM. Regulatory functions of the vascular endothelium. N Engl J Med 1990;323:27-36.
42. Dzau VJ, Gibbons GH, Cooke JP, Omoigui N. Vascular biology and medicine in the 1990s: scope, concepts, potentials, and perspectives. Circulation 1993;87:705-19.
43. Zeiher AM, Drexler H, Wollschläger H, Just H. Modulation of coronary vasomotor tone in humans: progressive endothelial dysfunction with different early stages of coronary atherosclerosis. Circulation 1991;83:391-401.
44. Kugiyama K, Yasue H, Okumura K, et al. Nitric oxide production is deficient in spasm arteries of patients with coronary spastic angina. Circulation 1996;94:266-72.
45. Yasue H, Horio Y, Nakamura N, et al. Induction of coronary spasm by acetylcholine in patients with variant angina: possible role of the parasympathetic nervous system in the pathogenesis of coronary artery spasm. Circulation 1986;74:955-63.
46. Miller VM, Vanhoutte PM. Progesterone and modulation of endothelium-dependent responses in canine coronary arteries. Am J Physiol 1991;261: R1022-7.